These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 25640063)
21. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance. Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025 [TBL] [Abstract][Full Text] [Related]
22. CD44 as a marker in human cancers. Sy MS; Mori H; Liu D Curr Opin Oncol; 1997 Jan; 9(1):108-12. PubMed ID: 9090502 [TBL] [Abstract][Full Text] [Related]
23. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44 de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216 [TBL] [Abstract][Full Text] [Related]
24. MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis. Min A; Zhu C; Peng S; Rajthala S; Costea DE; Sapkota D Biomed Res Int; 2015; 2015():186904. PubMed ID: 26504785 [TBL] [Abstract][Full Text] [Related]
25. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma. Mohanta S; Sekhar Khora S; Suresh A Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296 [TBL] [Abstract][Full Text] [Related]
26. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters. Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102 [TBL] [Abstract][Full Text] [Related]
27. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State. Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147 [TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma. Sawant S; Ahire C; Dongre H; Joshi S; Jamghare S; Rane P; Kane S; Chaukar D J Oral Pathol Med; 2018 Aug; 47(7):665-673. PubMed ID: 29752852 [TBL] [Abstract][Full Text] [Related]
29. Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma. Benhamou Y; Picco V; Raybaud H; Sudaka A; Chamorey E; Brolih S; Monteverde M; Merlano M; Lo Nigro C; Ambrosetti D; Pagès G Oncotarget; 2016 Jul; 7(28):44236-44251. PubMed ID: 27329590 [TBL] [Abstract][Full Text] [Related]
30. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998 [TBL] [Abstract][Full Text] [Related]
31. Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma. Lazarevic M; Milosevic M; Trisic D; Toljic B; Simonovic J; Nikolic N; Mikovic N; Jelovac D; Petrovic M; Vukadinovic M; Milasin J J BUON; 2018; 23(6):1686-1692. PubMed ID: 30610795 [TBL] [Abstract][Full Text] [Related]
32. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients. Velmurugan BK; Yeh KT; Lee CH; Lin SH; Chin MC; Chiang SL; Wang ZH; Hua CH; Tsai MH; Chang JG; Ko YC Oncotarget; 2016 Mar; 7(10):10879-90. PubMed ID: 26918356 [TBL] [Abstract][Full Text] [Related]
34. Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line. Ketkaew Y; Osathanon T; Pavasant P; Sooampon S Arch Oral Biol; 2017 Feb; 74():69-74. PubMed ID: 27886571 [TBL] [Abstract][Full Text] [Related]
35. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma. Khammanivong A; Gopalakrishnan R; Dickerson EB Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937 [TBL] [Abstract][Full Text] [Related]
36. Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells. Ohkoshi E; Umemura N Int J Oncol; 2017 Feb; 50(2):387-395. PubMed ID: 28035370 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122 [TBL] [Abstract][Full Text] [Related]
38. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Bourguignon LYW; Earle C; Shiina M Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080 [TBL] [Abstract][Full Text] [Related]
39. CD44, γ-H2AX, and p-ATM Expressions in Short-Term Ex Vivo Culture of Tumour Slices Predict the Treatment Response in Patients with Oral Squamous Cell Carcinoma. Philouze P; Gauthier A; Lauret A; Malesys C; Muggiolu G; Sauvaigo S; Galmiche A; Ceruse P; Alphonse G; Wozny AS; Rodriguez-Lafrasse C Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055060 [TBL] [Abstract][Full Text] [Related]
40. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma. Lee HJ; Kang YH; Lee JS; Byun JH; Kim UK; Jang SJ; Rho GJ; Park BW BMC Oral Health; 2015 Dec; 15(1):153. PubMed ID: 26626427 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]